Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk M Nettelbeck

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Oncotarget|January 30, 2016
Delivery of improved oncolytic adenoviruses by mesenchymal stromal cells for elimination of tumorigenic pancreatic cancer cellsAdam Kaczorowski, Katharina Hammer, Li Liu, et al.
Virology|October 27, 2009
Transgene expression by oncolytic adenoviruses is modulated by E1B19K deletion in a cell type-dependent mannerStanimira Rohmer, Christina Quirin, Andrea Hesse, et al.
Journal of Virology|January 20, 2012
Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of the viral capsidXavier Allaume, Nazim El-Andaloussi, Barbara Leuchs, et al.
Human Gene Therapy|October 18, 2021
Gene Therapy "Made in Germany": A Historical Perspective, Analysis of the Status Quo, and Recommendations for Action by the German Society for Gene TherapyHildegard Büning, Boris Fehse, Zoltán Ivics, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
Inhibition of melanoma growth by targeting of antigen to dendritic cells via an anti-DEC-205 single-chain fragment variable moleculeTheron S Johnson, Karsten Mahnke, Volker Storn, et al.
The Journal of Investigative Dermatology|December 11, 2012
Chemovirotherapy of malignant melanoma with a targeted and armed oncolytic measles virusJohanna K Kaufmann, Sascha Bossow, Christian Grossardt, et al.
International Journal of Oncology|October 4, 2007
An oncolytic adenoviral vector carrying the tyrosinase promoter for glioma gene therapyIlya V Ulasov, Angel A Rivera, Dirk M Nettelbeck, et al.
International Journal of Cancer|October 11, 2014
Genetic delivery of an immunoRNase by an oncolytic adenovirus enhances anticancer activityInés Fernández-Ulibarri, Katharina Hammer, Michaela A E Arndt, et al.
Human Gene Therapy|May 18, 2004
Genetic replacement of the adenovirus shaft fiber reduces liver tropism in ovarian cancer gene therapyMartina Breidenbach, Daniel T Rein, Minghui Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 4, 2006
Triple-targeted oncolytic adenoviruses featuring the cox2 promoter, E1A transcomplementation, and serotype chimerism for enhanced selectivity for ovarian cancer cellsGerd J Bauerschmitz, Kilian Guse, Anna Kanerva, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Oncotarget|January 30, 2016
Delivery of improved oncolytic adenoviruses by mesenchymal stromal cells for elimination of tumorigenic pancreatic cancer cellsAdam Kaczorowski, Katharina Hammer, Li Liu, et al.
Virology|October 27, 2009
Transgene expression by oncolytic adenoviruses is modulated by E1B19K deletion in a cell type-dependent mannerStanimira Rohmer, Christina Quirin, Andrea Hesse, et al.
Journal of Virology|January 20, 2012
Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of the viral capsidXavier Allaume, Nazim El-Andaloussi, Barbara Leuchs, et al.
Human Gene Therapy|October 18, 2021
Gene Therapy "Made in Germany": A Historical Perspective, Analysis of the Status Quo, and Recommendations for Action by the German Society for Gene TherapyHildegard Büning, Boris Fehse, Zoltán Ivics, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
Inhibition of melanoma growth by targeting of antigen to dendritic cells via an anti-DEC-205 single-chain fragment variable moleculeTheron S Johnson, Karsten Mahnke, Volker Storn, et al.
The Journal of Investigative Dermatology|December 11, 2012
Chemovirotherapy of malignant melanoma with a targeted and armed oncolytic measles virusJohanna K Kaufmann, Sascha Bossow, Christian Grossardt, et al.
International Journal of Oncology|October 4, 2007
An oncolytic adenoviral vector carrying the tyrosinase promoter for glioma gene therapyIlya V Ulasov, Angel A Rivera, Dirk M Nettelbeck, et al.
International Journal of Cancer|October 11, 2014
Genetic delivery of an immunoRNase by an oncolytic adenovirus enhances anticancer activityInés Fernández-Ulibarri, Katharina Hammer, Michaela A E Arndt, et al.
Human Gene Therapy|May 18, 2004
Genetic replacement of the adenovirus shaft fiber reduces liver tropism in ovarian cancer gene therapyMartina Breidenbach, Daniel T Rein, Minghui Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 4, 2006
Triple-targeted oncolytic adenoviruses featuring the cox2 promoter, E1A transcomplementation, and serotype chimerism for enhanced selectivity for ovarian cancer cellsGerd J Bauerschmitz, Kilian Guse, Anna Kanerva, et al.
Pageof 7